Off-Target Effects of Psychoactive Drugs Revealed by Genome-Wide Assays in Yeast
2008

Understanding Off-Target Effects of Psychoactive Drugs Using Yeast

Sample size: 214 publication 10 minutes Evidence: high

Author Information

Author(s): Ericson Elke, Gebbia Marinella, Heisler Lawrence E., Wildenhain Jan, Tyers Mike, Giaever Guri, Nislow Corey

Primary Institution: University of Toronto

Hypothesis

To better understand off-target effects of widely prescribed psychoactive drugs, we performed a comprehensive series of chemogenomic screens using the budding yeast Saccharomyces cerevisiae as a model system.

Conclusion

The study identified 81 psychoactive drugs that inhibited yeast growth and revealed that many of these drugs affect multiple cellular functions, suggesting potential secondary drug targets.

Supporting Evidence

  • Among 214 tested psychoactive drugs, 81 were found to inhibit yeast growth.
  • Half of the analyzed drugs affected core cellular processes such as secretion and RNA processing.
  • Fluoxetine was found to interfere with cell polarity, while paroxetine affected RNA metabolism.

Takeaway

Researchers tested many drugs on yeast to see how they affect cells, finding that some drugs can mess with important cell functions.

Methodology

The study used genome-wide deletion strains of yeast to assess drug sensitivity and identify off-target effects through chemogenomic profiling.

Limitations

The study's findings may not fully translate to human biology due to differences between yeast and human cellular processes.

Statistical Information

P-Value

p<10−7

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1371/journal.pgen.1000151

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication